Progression to the phase 2b cohort follows recommendation of the Safety Review Committee (SRC) after it reviewed positive ...

Stockhead’s Fraser Palamara sits down with Island Pharmaceuticals (ASX:ILA)  CEO and managing director David Foster to get the short end of the long story on the company’s latest news.

Long Island schools have produced dozens of scholars year after year. The region had 50 semifinalists last year and three of ...

Dual-listed regenerative medicine company Avita Medical has seen its share price slide ~19% today on a downgrade of its ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("we" or "Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...

Island Pharmaceuticals Ltd (AU:ILA) has released an update. Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter ...

Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Island Pharmaceuticals Ltd is set to hold an Extraordinary General Meeting on January 28, 2025, encouraging ...

Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Island Pharmaceuticals Limited has announced a significant change in the interests of its Director, Dr. David ...

Island Pharmaceuticals Ltd (AU:ILA) has released an update. Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Alagappan said Prodose, which officially took over the assets of the defunct Spirit Pharmaceuticals on Nov ... square-foot building south of Long Island MacArthur Airport and the consolidation ...